W. Kimryn Rathmell

W. Kimryn Rathmell is the Chair of Medicine and Physician-in-Chief at Vanderbilt University Medical Center. She is a physician-scientist studying the molecular biology of renal cell carcinomas and rare tumors of the kidney. Her research program focuses on understanding the molecular pathogenesis of renal cell carcinomas and spans early models of renal tumorigenesis; novel imaging strategies for diagnosis and screening of kidney cancer; epigenetic regulation of kidney cancers; metabolic features of tumorigenesis; and novel therapeutic strategies to overcome resistance to anti-angiogenic therapy and checkpoint targeted immunotherapy. Rathmell is also an advocate physician-scientist training and has directed several mentoring and career development programs.

Rathmell is a member of The Cancer Genome Atlas, winning the 2021 American Association for Cancer Research Team Science Award, and serves on the National Cancer Institute’s Board of Scientific Advisors and on the Forbeck Foundation Scientific Board of Directors. She is a senior editor for eLIFE, and has served on editorial boards for JCI, Kidney Cancer, and JCO-Precision Oncology. She has held leadership positions for the American Society of Clinical Oncology, the Kidney Cancer Research Foundation, and the American Society for Clinical Investigation, and is a member of the National Academy of Medicine. She holds an M.D. and Ph.D. from Stanford University.